Recent studies have shown that chemotherapy can activate the cGAS-STING pathway in cancer cells, leading to an innate immune activation and recruitment of immune cells to the tumor microenvironment, which may contribute to the antitumor effects of these drugs (13, 14). The gene discussed is STING1; the disease is neoplasm.